Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, May 23, 2013
Technology Networks
 
Register | Sign in
Home Page
  About Us

Technology Networks

Technology Networks were established over 10 years ago with the aim of providing informative websites for life science professionals.

From our UK headquarters near Sudbury, in Suffolk, we run, update and provide an outstanding web-based information solution for those working within the Life Science and Drug Discovery community.

Since its humble beginnings running just one website based on Combinatorial Chemistry, Technology Networks has expanded its portfolio to include over 30 communities. All of which are available through TechnologyNetworks.com

Our Communities
Agrigenomics Biologics and Bioprocessing
Biomolecular Screening Cell Culture Chemical Process Scale Up
Chromotography Crystallography Environmental Analysis
ePosters Food and Beverage Gene Silencing
Genomics Genotyping and Gene Expression Immunology
Informatics Lab-on-a-Chip
LIMs and ELNs Market Reports Mass Spectrometry
Medicinal Chemistry Metabolomics and Lipidomics Molecular and Clinical Diagnostics
Next Gen Sequencing PharmaOutsourcing Proteomics
qPCR Spectroscopy Stem Cells, Cellular Therapy & Biobanking

Scientific News
Program for Breakthrough Biomedical Research to Celebrate 15 Years
A program that fosters basic science projects of potentially high impact is celebrating 15 years of discovery at UC San Francisco.
UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
Team Successfully Converts Human Skin Cells into Embryonic Stem Cells
The breakthrough marks the first time human stem cells have been produced via nuclear transfer and follows several unsuccessful attempts by research groups worldwide.
Nobel Prize Rockets Stem Cell Program to New Heights
Shinya Yamanaka's Feat Brings fresh attention to promise of regeneration medicine.
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine
Companies announce agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.
Stem Cells Show Promise for Treating Rare Nerve Disease
Scientists have used iPS cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia (A-T).
Two MIT Professors Named Howard Hughes Medical Institute Investigators
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.
Cell Therapy Promise Highlighted at UCSF Symposium
Old-line pharmaceutical companies and maturing biotech businesses both are graybeards compared to newer ventures focused on cell therapy.
Researchers Chart Epigenomics of Stem Cells That Mimic Early Human Development
Collaborative study will help overcome hurdles to using stem cells to treat diseases and injuries.
NYSCF Scientists Create Personalized Bone Substitutes from Skin Cells
For treatment of large bone defects and traumatic injuries.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net